BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28407345)

  • 1. Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early-stage prostate cancer.
    Xiang HF; Lu HM; Efstathiou JA; Zietman AL; De Armas R; Harris K; Bloch BN; Qureshi MM; Keohan S; Hirsch AE
    J Appl Clin Med Phys; 2017 May; 18(3):37-43. PubMed ID: 28407345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon.
    Jones BL; Gan G; Diot Q; Kavanagh B; Timmerman RD; Miften M
    Med Phys; 2012 Jun; 39(6):3080-8. PubMed ID: 22755693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
    Dubouloz A; Rouzaud M; Tsvang L; Verbakel W; Björkqvist M; Linthout N; Lencart J; Pérez-Moreno JM; Ozen Z; Escude L; Zilli T; Miralbell R
    Radiat Oncol; 2018 Jun; 13(1):114. PubMed ID: 29921291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of endorectal balloon positioning errors on target deformation and dosimetric quality during prostate SBRT.
    Jones BL; Gan G; Kavanagh B; Miften M
    Phys Med Biol; 2013 Nov; 58(22):7995-8006. PubMed ID: 24169860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the use of an endorectal balloon on rectal dosimetry during stereotactic body radiation therapy for localized prostate cancer.
    Wong AT; Schreiber D; Agarwal M; Polubarov A; Schwartz D
    Pract Radiat Oncol; 2016; 6(4):262-267. PubMed ID: 26725959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.
    Chapet O; Udrescu C; Tanguy R; Ruffion A; Fenoglietto P; Sotton MP; Devonec M; Colombel M; Jalade P; Azria D
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):425-32. PubMed ID: 24411613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
    Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR
    Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose optimization and endorectal balloon for internal pudendal arteries sparing in prostate SBRT.
    Jaccard M; Lamanna G; Dubouloz A; Rouzaud M; Miralbell R; Zilli T
    Phys Med; 2019 May; 61():28-32. PubMed ID: 31151576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.
    Fukuda S; Seo Y; Shiomi H; Yamada Y; Ogata T; Morimoto M; Konishi K; Yoshioka Y; Ogawa K
    J Radiat Res; 2014 Nov; 55(6):1114-21. PubMed ID: 24957754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.
    Kishan AU; Park SJ; King CR; Roberts K; Kupelian PA; Steinberg ML; Kamrava M
    Br J Radiol; 2015; 88(1056):20150658. PubMed ID: 26463234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study.
    Ahmad Khalil D; Wulff J; Jazmati D; Geismar D; Bäumer C; Kramer PH; Steinmeier T; Schleithoff SS; Tschirdewahn S; Hadaschik B; Timmermann B
    Curr Oncol; 2023 Jan; 30(1):758-768. PubMed ID: 36661707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
    Kole TP; Nichols RC; Lei S; Wu B; Huh SN; Morris CG; Lee S; Tong M; Mendenhall NP; Dritschilo A; Collins SP
    Acta Oncol; 2015 Jun; 54(6):825-31. PubMed ID: 25227898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
    Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plan quality and dosimetric association of patient-reported rectal and urinary toxicities for prostate stereotactic body radiotherapy.
    Qi XS; Wang JP; Gomez CL; Shao W; Xu X; King C; Low DA; Steinberg M; Kupelian P
    Radiother Oncol; 2016 Oct; 121(1):113-117. PubMed ID: 27587270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric effects of the acuros XB and anisotropic analytical algorithm on volumetric modulated arc therapy planning for prostate cancer using an endorectal balloon.
    Koo T; Chung JB; Eom KY; Seok JY; Kim IA; Kim JS
    Radiat Oncol; 2015 Feb; 10():48. PubMed ID: 25890071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric parameters predict short-term quality-of-life outcomes for patients receiving stereotactic body radiation therapy for prostate cancer.
    Gomez CL; Xu X; Qi XS; Wang PC; Kupelian P; Steinberg M; King CR
    Pract Radiat Oncol; 2015; 5(4):257-62. PubMed ID: 25749214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.
    Wahl M; Descovich M; Shugard E; Pinnaduwage D; Sudhyadhom A; Chang A; Roach M; Gottschalk A; Chen J
    Technol Cancer Res Treat; 2017 Apr; 16(2):178-187. PubMed ID: 27199276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly-developed tumor-tracking system and cyberknife.
    Manabe Y; Hashimoto S; Mukouyama H; Shibamoto Y
    J Appl Clin Med Phys; 2021 Oct; 22(10):66-72. PubMed ID: 34415658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.